Viewing nowMontelukast Chewable Tablet 5mg (Montelukast Sodium)
Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 201800306 · Approved 2018.01.23 · Insurance code 665002420
Prevention and maintenance treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
This medication helps prevent asthma attacks and provides ongoing treatment. It is also used to relieve symptoms of seasonal and year-round allergic rhinitis.
This medicine should be taken once daily. Patients with asthma should take it in the evening, while the dosing time for patients with allergic rhinitis should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. Adults and adolescents 15 years of age and older: Administer 10 mg of montelukast orally once daily. Adults and adolescents 15 years of age and older: Place 10 mg of montelukast on the tongue once daily and take without water after it disintegrates. Adults and adolescents 15 years of age and older: Place 10 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water.
Children 6~14 years: Chew and take 5 mg of montelukast once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children 2~5 years: Chew and take 4 mg of montelukast once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children 6~14 years: Place 5 mg of montelukast on the tongue and take without water once it has disintegrated. Administer this medicine 1 hour before or 2 hours after a meal. Children 2~5 years: Place 4 mg of montelukast on the tongue and take without water once it has disintegrated. Administer this medicine 1 hour before or 2 hours after a meal. Children 6~14 years: Place 5 mg of montelukast on the tongue and let it dissolve; take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children 2~5 years: Place 4 mg of montelukast on the tongue and let it dissolve; take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children 6~14 years: Administer 5mg of montelukast orally once daily. Administer this medicine 1 hour before or 2 hours after a meal. Asthma — Children 2~5 years: Administer 4 mg of montelukast orally once daily. Asthma — Infants 12 months~under 2 years: Administer 4 mg of this medicine orally once daily in the evening. Asthma — Efficacy and safety for asthma have not been established in infants under 12 months. Allergic rhinitis — Children 2~5 years: Administer 4 mg of montelukast orally once daily. Allergic rhinitis — Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years. Allergic rhinitis — Infants 6 months~under 2 years: Administer 4mg of this medicine orally once daily. Allergic rhinitis — Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months.
This medication may affect the nervous system, leading to symptoms such as agitation, aggressive behavior, anxiety, depression, sleep disturbances, hallucinations, memory issues, and suicidal thoughts. Therefore, if any new symptoms or behavioral changes occur during treatment, notify your physician immediately. This medication contains the artificial sweetener aspartame, so patients with the genetic disorder phenylketonuria should avoid taking it. Care should be taken not to exceed the WHO recommended daily intake of aspartame. This medication contains lactose, so it should not be administered to patients with genetic disorders such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. This medication is not intended for the treatment of acute asthma attacks, so patients should always carry and use appropriate emergency medication if acute symptoms occur. It should not be used alone to treat exercise-induced bronchospasm; a rescue β-agonist should be taken if necessary. Patients with aspirin hypersensitivity should avoid taking aspirin or non-steroidal anti-inflammatory drugs while taking this medication. During treatment, do not abruptly stop or switch inhaled or oral corticosteroids without a doctor's guidance. In case of overdose, there is no specific antidote, so general symptomatic treatment and clinical monitoring are necessary. During pregnancy, use only if absolutely necessary, and caution is needed while breastfeeding. Safety and efficacy have not been established for children, especially those under 6 months. Elderly patients do not show significant differences in safety, but care should be taken as their response to the medication may vary. During treatment, do not arbitrarily reduce or stop the doses of other asthma medications, and consult with a doctor if symptoms worsen. Lastly, keep this medication out of reach of children and ensure it is not transferred to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to moisture and light, so it should be stored at room temperature between 1 to 30 degrees Celsius. Furthermore, it is important to store it in an airtight container to maintain its effectiveness.
Biconvex, round, pink chewable tablet
28 tablets (7 tablets/PTP x 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.